These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7917768)

  • 21. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
    Constenla M
    Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.
    Wolf H
    Scand J Rheumatol Suppl; 2000; 113():37-45. PubMed ID: 11028830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of 5-HT3 receptor antagonists, particularly as anti-emetic drugs].
    Lechat P
    Ann Pharm Fr; 1991; 49(6):307-16. PubMed ID: 1842169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
    Rizk AN; Hesketh PJ
    Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
    Darmani NA
    J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ondansetron. Therapeutic use as an antiemetic.
    Milne RJ; Heel RC
    Drugs; 1991 Apr; 41(4):574-95. PubMed ID: 1711961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
    Salvo N; Doble B; Khan L; Amirthevasar G; Dennis K; Pasetka M; Deangelis C; Tsao M; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):408-17. PubMed ID: 21075553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
    Alon E; Biro P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 May; 31(4):200-4. PubMed ID: 8704077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy-induced emesis in elderly cancer patients: the role of 5-HT3-receptor antagonists in the first 24 hours.
    Aapro M; Johnson J
    Gerontology; 2005; 51(5):287-96. PubMed ID: 16110229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research on antiemetics: an Italian model of success].
    Roila F
    Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis.
    Lindley C; Blower P
    Am J Health Syst Pharm; 2000 Sep; 57(18):1685-97. PubMed ID: 11006796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological agents affecting emesis. A review (Part I).
    Mitchelson F
    Drugs; 1992 Mar; 43(3):295-315. PubMed ID: 1374316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of propofol on ipecacuanha-induced nausea and vomiting.
    Hammas B; Hvarfner A; Thörn SE; Wattwil M
    Acta Anaesthesiol Scand; 1998 Apr; 42(4):447-51. PubMed ID: 9563865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of oral 5-HT3 receptor antagonists for emetogenic chemotherapy.
    Anastasia PJ
    Oncol Nurs Forum; 2000 Apr; 27(3):483-93. PubMed ID: 10785902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
    Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological and anti-emetic properties of ondansetron.
    Tyers MB; Bunce KT; Humphrey PP
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Betamethasone does not prevent nausea and vomiting induced by ipecacuanha.
    Axelsson P; Thörn SE; Wattwil M
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1283-6. PubMed ID: 15504189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action.
    Freeman AJ; Cunningham KT; Tyers MB
    Anticancer Drugs; 1992 Apr; 3(2):79-85. PubMed ID: 1525396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.